Skip to content

Dexamethasone analgesic effect in pectoral nerve block for mastectomy

Dexamethasone as an adjuvant analgesic in pectoral nerve block for mastectomy: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201906524333727
Enrollment
54
Registered
2019-06-19
Start date
2019-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

group 1 dexamethasone

Sponsors

suez canal university hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Patients scheduled for elective unilateral modified radical mastectomy age from 18 to 60 years ASA class I OR II

Exclusion criteria

Exclusion criteria: -Patients with contraindication to pectoral nerve block e.g. (allergy from bupivacaine - skin infection at the site of injection - coagulopathy) - Patients received chemotherapy or radiotherapy. - Patients complaining from any psychotic. -Pregnant or lactating mothers. -History of drug dependency or substance addiction. -Patients complaining of chronic pain or on regular analgesic medication.

Design outcomes

Primary

MeasureTime frame
total postoperative morphine consumption over 48 hours

Secondary

MeasureTime frame
postoperative VAS pain score at rest and on movement ;the time of first postoperative request of analgesia ;hemodynamics systolic blood pressure, diastolic blood pressure, mean blood pressure, heart rate;intraoperative fentanyl consumption;Ramsay sedation scale;postoperative nausea and vomiting;postsurgical hospital stay;postoperative complications

Countries

Egypt

Contacts

Public Contacthamdy hendawy

lecturer of anesthesia intensive care and pain management at faculty of medicine suez canal university

hamdy.hendawy@med.suez.edu.eg00201143667734

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026